Suppr超能文献

正常下降睾丸和隐睾的精原细胞瘤。

Seminoma of normally-descended and cryptorchid testis.

作者信息

Sham J S, Choy D, Chan K W, Choi P H

机构信息

Department of Radiotherapy and Oncology, University of Hong Kong, Queen Mary Hospital.

出版信息

Eur J Surg Oncol. 1990 Feb;16(1):33-6.

PMID:1968400
Abstract

The records of 40 patients with seminoma of testis were reviewed; nine had cryptorchidism. The incidence of cryptorchidism among the 36 Chinese patients was 22% (8/36). All Stage I and four Stage II patients were treated by orchidectomy followed by radiotherapy of 30 Gy or more to the pelvic and para-aortic lymphatics, while another seven Stage II patients received pelvic and para-aortic lymphatics plus mediastinal irradiation. For patients with normally-descended testis, the 2-year survival for Stage I was 94% and Stage II, with small and clinically unpalpable abdominal nodal metastases, 86%. For patients with Stage I and II seminoma arising from cryptorchid testis, comparable survival can be achieved by giving similar doses of radiation and adjusting the size of the para-aortic and pelvic radiation fields to cover the known extent of the disease. The prognosis of patients with seminoma arising from cryptorchid testis depends more on the stage and extent of disease than the status of cryptorchid testis. Painful groin mass or abdominal pain were the presenting symptoms in more than half of the patients with cryptorchid testes. The changed symptomatology in this group of patients can result in diagnosis delay.

摘要

回顾了40例睾丸精原细胞瘤患者的记录;其中9例患有隐睾症。36例中国患者中隐睾症的发生率为22%(8/36)。所有I期和4例II期患者均接受睾丸切除术,随后对盆腔和腹主动脉旁淋巴结进行30 Gy或更高剂量的放疗,而另外7例II期患者接受盆腔和腹主动脉旁淋巴结加纵隔照射。对于睾丸正常下降的患者,I期的2年生存率为94%,II期且腹部淋巴结转移较小且临床触诊不到的患者为86%。对于由隐睾引起的I期和II期精原细胞瘤患者,通过给予相似剂量的放疗并调整腹主动脉旁和盆腔放疗野的大小以覆盖已知疾病范围,可实现相似的生存率。由隐睾引起的精原细胞瘤患者的预后更多地取决于疾病的分期和范围,而非隐睾的状态。超过一半的隐睾患者以腹股沟肿块疼痛或腹痛为首发症状。该组患者症状的改变可能导致诊断延迟。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验